← Open Payments lookup

AMANDA DAVIS: Open Payments

NPI 1790220143 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,191 in 41 payments from 9 companies in 2025. Trend: 2023 $18,270 · 2024 $18,974 · 2025 $5,191

Consulting: $1,840Travel & lodging: $1,396Speaker / faculty: $1,130Food & beverage: $826
CompanyPaymentsAmount
Gilead Sciences, Inc.18$4,706
Ipsen Biopharmaceuticals, Inc13$217
Regeneron Healthcare Solutions, Inc.2$76
Madrigal Pharmaceuticals2$58
ABBVIE INC.2$55
Janssen Biotech, Inc.1$25
ORPHALAN INC1$19
Novo Nordisk Inc1$18
Ardelyx, Inc.1$17

Products named: Epclusa, IQIRVO, DUPIXENT, REZDIFFRA, MAVYRET, TREMFYA, CUVRIOR, Bylvay.

Industry payments across AR — which companies pay providers there.